SHALINI BHARDWAJ

All stories by SHALINI BHARDWAJ

AIIMS getting over 100 conjunctivitis cases per day

AIIMS getting over 100 conjunctivitis cases per day

Rediff.com26 Jul 2023

One of the private eye care hospitals in Delhi has reported 1,032 cases of conjunctivitis in Delhi-NCR and 1,521 cases pan India.

As 11 Omicron variants detected in India, govt says...

As 11 Omicron variants detected in India, govt says...

Rediff.com5 Jan 2023

Union Health Minister Mansukh Mandaviya on Thursday asked the public not to panic about COVID-19, but be alert and follow the directives issued by the government from time to time.

Crucial meet today on genome sequencing of positive Covid samples

Crucial meet today on genome sequencing of positive Covid samples

Rediff.com30 Dec 2022

It's expected that INSACOG will be once again releasing a bulletin from next week on updates about the types of variants present in India.

Covid: Omicron, sub-lineages dominant variant in India

Covid: Omicron, sub-lineages dominant variant in India

Rediff.com6 Aug 2022

"The COVID-19 cases are rising, but hospitalization and deaths are still less," said sources.

Experts raise alarm after first monkeypox death, lay stress on surveillance

Experts raise alarm after first monkeypox death, lay stress on surveillance

Rediff.com2 Aug 2022

After confirmation of the first monkeypox death in the country by the National Institute of Virology, health experts advised strengthening the surveillance to avoid silent transmission of monkeypox.

'Unscientific to consider 2 doses as full vaccination'

'Unscientific to consider 2 doses as full vaccination'

Rediff.com26 Apr 2022

'If a fourth wave comes it will be a total surprise to me'

Bharat Biotech to rectify issues with Covaxin raised by WHO

Bharat Biotech to rectify issues with Covaxin raised by WHO

Rediff.com5 Apr 2022

According to sources close to ANI, "Bharat Biotech has informed Union health ministry that it will rectify the issues pointed out by WHO in 15 to 20 days." "World Health Organisation (WHO)'s suspension is not related to safety or efficacy issues but limited only to supply for United Nations agencies."

Omicron BA.2 will not lead to another Covid surge in India, says expert

Omicron BA.2 will not lead to another Covid surge in India, says expert

Rediff.com21 Feb 2022

"It will not cause another surge. BA.2 is not capable of infecting people who had BA.1. It's not a new virus or strain. BA.2 is a sub-lineage of Omicron," Dr Jayadevan said.

First nasal spray for treating Covid patients launched in India

First nasal spray for treating Covid patients launched in India

Rediff.com9 Feb 2022

The company claims that when the Nitric Oxide Nasal is sprayed over nasal mucosa it acts as a physical and chemical barrier against the virus.

Omicron in community transmission stage in India: INSACOG

Omicron in community transmission stage in India: INSACOG

Rediff.com23 Jan 2022

The Omicron variant of COVID-19 is in the community transmission stage in India and it has also become dominant in multiple metros, where new cases have been rising exponentially, said Indian SARS-CoV-2 Genomics Consortium.

3rd wave has reached its peak in Delhi, Mumbai, Kolkata: IIT prof

3rd wave has reached its peak in Delhi, Mumbai, Kolkata: IIT prof

Rediff.com18 Jan 2022

He said that southern states like Andhra Pradesh, Karnataka and Tamil Nadu will see the current wave peak next week.

Human trials of India's 1st mRNA vaccine to start in February

Human trials of India's 1st mRNA vaccine to start in February

Rediff.com17 Jan 2022

The Pune-based Gennova Biopharmaceuticals has submitted phase 2 data of mRNA vaccine and has also completed the recruitment of phase 3 data.

India may see 5 lakh Covid cases daily next month: Expert

India may see 5 lakh Covid cases daily next month: Expert

Rediff.com8 Jan 2022

'There will be many Omicron cases in India, but much less hospitalisation and death than you had in the Delta wave'

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Covid infection is not severe in kids, send them to school: Dr Gagandeep Kang

Rediff.com31 Dec 2021

"In children, fortunately, infections with SARS-CoV-2 are generally not severe. There is a risk of long COVID, there is a risk of a very, very rare condition called MISC (Multisystem Inflammatory Syndrome) but by and large healthy children have nothing," said Dr Gagandeep Kang, leading Indian virologist.

Covaxin has shown good response in kids: Govt panel doc

Covaxin has shown good response in kids: Govt panel doc

Rediff.com27 Dec 2021

He explained, "Children between the age of 12 and 18 years, particularly those in the age group of 15 to 18 years, are very much like adults. Our research within the country also says that almost two-thirds of the deaths below 18 years which occurred due to COVID in India are within this age group. So, this decision was mainly taken to protect the adolescents."

Comorbidities proof must for 60+ to get booster, says NHA chief

Comorbidities proof must for 60+ to get booster, says NHA chief

Rediff.com26 Dec 2021

The elderly population above 60 years of age with comorbidities who are eligible for COVID-19 'precautionary doses' will have to take a medical certificate to take the dose, informed chief executive officer of National Health Authority Dr RS Sharma

Omicron driven third Covid wave in India may peak in Feb: Covid Panel

Omicron driven third Covid wave in India may peak in Feb: Covid Panel

Rediff.com19 Dec 2021

Daily COVID-19 caseload in India that is currently around 7,500 infections is expected to increase once the Omicron starts displacing Delta as the dominant variant, informed members of the national COVID-19 supermodel committee and predicted the third wave in India early year.

Omicron cases a wake-up call for India: Expert

Omicron cases a wake-up call for India: Expert

Rediff.com5 Dec 2021

Dr Mishra further explained the effect of hybrid immunity on the vaccinated population and said that it is likely to give protection to people along with the Indian vaccines administered.

Omicron has been around for some time, says SA doctor who raised alarm

Omicron has been around for some time, says SA doctor who raised alarm

Rediff.com3 Dec 2021

Omicron very different from Delta, Beta COVID variants, says South African doctor Angelique Coetzee.

Omicron scare: SII seeks approval for Covishield booster

Omicron scare: SII seeks approval for Covishield booster

Rediff.com2 Dec 2021

The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose.

Next